PRL and neoplasm: In this light, the achievement of a > 90% suppression of PRL levels and a substantial tumour shrinkage have been proposed as the main criteria for the systematic evaluation of the outcomes of medical treatment with cabergoline before a trial of drug discontinuation was experimented in clinical settings [65].